Linking hospital patient records for suspected or established acute coronary syndrome in a complex secondary care system : a proof-of-concept e-registry in National Health Service Scotland by Findlay, Iain et al.
Linking hospital patient records for
suspected or established acute coronary
syndrome in a complex secondary care
system: a proof-of-concept e-registry in
National Health Service Scotland
Iain Findlay1, Tamsin Morris2, Ruiqi Zhang3, Colin McCowan3, Sarah Shield2,
Brian Forbes2, Alex McConnachie3, Kenneth Mangion4, and Colin Berry4,5*
1Royal Alexandra Hospital, NHS Greater Glasgow and Clyde Health Board, Corsebar Road, Paisley PA2 9PN, UK; 2AstraZeneca UK, Capability Green, Luton, LU1 3LU, UK;
3Robertson Centre for Biostatistics, University of Glasgow, G12 8QQ, UK; 4BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences,
University of Glasgow, 126 University Place, Glasgow, G12 8TA, Scotland, UK; and 5Golden Jubilee National Hospital, Agamemnon Street, G81 4DY, UK
Received 21 November 2017; revised 1 February 2018; editorial decision 5 February 2018; accepted 15 February 2018; online publish-ahead-of-print 16 February 2018
Aims To implement secondary care electronic record linkage for patients hospitalized with suspected or known acute
coronary syndrome (ACS) in a complex regional health care system and evaluate this e-Registry in terms of pat-
terns of service delivery and 1-year outcomes.
...................................................................................................................................................................................................
Methods
and results
Existing electronic hospital records were linked to create episodes of care using (i) a patient administration system, (ii)
invasive cardiovascular procedure referrals, and (iii) a catheter laboratory record. Data were extracted for admissions
(1 October 2013–30 September 2014) with International Classification of Disease (ICD)-10 diagnosis of angina
(I200–I209), myocardial infarction (I210–I229), other ischaemic heart disease (I240–I249) or heart failure (I50),
linked to other sources to develop a secondary care ACS e-registry and analysed within a Safe Haven. Episodes
of care were categorized into care pathways and evaluated in terms of patient characteristics, as well as service
delivery metrics and outcomes including mortality. In all, 2327 patients had 2472 episodes of care. Diagnoses
were hierarchically classified as ST-elevation myocardial infarction (STEMI) (586, 25.2%), non-ST-elevation myo-
cardial infarction (NSTEMI) (1068, 45.9%), unspecified myocardial infarction (146, 6.3%), unstable angina (527,
22.6%) for the first hospitalization for each patient within the study period. Six care pathways were mapped.
Percutaneous coronary intervention rate for STEMI was 80.2% and for NSTEMI 33.1%. Unadjusted all-cause
mortality was 9.0% and 3.0% for STEMI and NSTEMI at 30 days, rising to 11.9% and 11.6% at 1 year. Analyses
were validated by independent source data verification.
...................................................................................................................................................................................................
Conclusion The e-registry has enabled analysis of ACS hospitalizations in a complex health care system with implications for
quality improvement and research.
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Introduction
Acute coronary syndrome (ACS) is a leading cause of premature ill-
ness and death, and one of the most common reasons for an emer-
gency admission to hospital.1,2 Reducing the public health burden from
ACS is a key priority for health care providers and governments.
In the United Kingdom (UK) in 2013/2014, there were 491 647 in-
patient episodes attributed to ischaemic heart disease (IHD),3 and
the number of myocardial infarction (MI) events being recorded in
England, Wales, and Northern Ireland has increased (2011/2012—
79 433; 2014/2015—83 842).4,5 The Myocardial Ischaemia National
Audit Project (MINAP) provides information on national standards of
care for patients with heart attack in England, Wales, and Northern
Ireland but not in Scotland, where joined-up systems for reporting
contemporary secondary care activities and related patient out-
comes are lacking. Such information has crucial importance as prac-
tice variation in ACS patients has been shown to be associated with
mortality,6–8 while comparative research across countries might help
to improve health systems and prevent deaths.9,10
The National Health Service (NHS) is the sole provider of second-
ary care services for hospitalized patients with an ACS in the UK.
Given the large number of patient episodes and the complexity of
this health care system, the process and outcome of individual pa-
tients who have been hospitalized with ACS is difficult to describe
and uncertain when based on individual hospital records alone.
The project was set up as a Joint Working Project between NHS
health boards, including Greater Glasgow and Clyde (NHS GGC)
and the Golden Jubilee National Hospital (GJNH) and AstraZeneca
UK Ltd. The overall aim of the project was to develop and implement
an updatable electronic registry (e-Registry), in a regional network
that provides secondary care for patients hospitalized for a known or
suspected ACS, with applications for audit, research, and health care
improvement. In addition, the project team wished to collaborate
and demonstrate that the pharmaceutical industry could work as a
trusted partner to the NHS in adding value to health care beyond
medicines through shared skills, expertise, and resources to further
enhance patient outcomes and service performance.
Methods
Setting
The e-Registry was established in the NHS in the West of Scotland.
During the study period, NHS GGC provided acute secondary care ser-
vices through seven hospitals serving a population of approximately 1.2
million. The GJNH is a regional cardiothoracic intervention centre that
provides invasive cardiology and cardiothoracic services for this popula-
tion, amongst others, but is administratively distinct from NHS GGC.
These hospitals participate in a Managed Clinical Network to provide
strategic health care delivery.
Semi-electronic patient records were implemented across all second-
ary care clinical and administration systems in NHS GGC and the GJNH
by June 201211,12 enabling capture of key components of ACS care.
Governance
The project was supported by the National Advisory Committee for
Coronary Heart Disease on behalf of the Scottish Government. The Joint
Working Project described within this report was approved by hospital
management and the Caldicott Guardian for clinical governance in each
Health Board.
Design and methodology
An executable system was developed to identify, extract, and link usual
care electronic health records for patients hospitalized with a suspected
or known ACS. No new clinical records or manual data entry from paper
archives were required. The Community Health Index (CHI) is a 10-digit
unique identifier for each person registered with a general practitioner in
Scotland and is present on almost all health care encounters. This identi-
fier was used to link the records of patients in the extracted data sets.
Hospital patient episodes were used to create episodes of care using
(i) the Intersystems TRAKCare Patient Admin System with data extracts
based on ICD-1013 diagnosis codes, (ii) Scottish Care Information (SCI)
Gateway14 electronic referrals for invasive cardiovascular procedures,
(iii) a bespoke hospital-level patient and catheter laboratory record de-
veloped in the GJNH (Figure 1).
Data were extracted from these core clinical systems used to manage
patients with ACS and deposited within an existing repository for elec-
tronic health data (an NHS Safe Haven).15 Patients within these data sets
were then linked to National Records Scotland (NRS) death certificates
where appropriate. The electronic records were pseudonymised within
the Safe Haven before being securely transferred to the analysts who
were employed by AstraZeneca UK Ltd under a data sharing agreement
signed by all parties. Statistical analysis was supported by a co-funded
PhD from the University of Glasgow.
The ACS diagnoses were based on the discharge summary recorded
by the attending clinician(s) in usual care health records captured in the
clinical systems. In the local hospital patient administration system
(TRAKCare), the diagnoses are subsequently coded per the International
Classification of Disease (ICD)-10 and in the invasive centre (IC) the dis-
charge diagnosis is recorded in a standardized text format. An algorithm
was developed to assign the most appropriate diagnosis to an episode of
care. Where a patient had multiple diagnoses in a linked episode of care
from different clinical settings or systems, the diagnosis on discharge from
the IC was taken as the most accurate representation. Where a patient
did not attend the IC as part of their care pathway, the ICD-10 diagnosis
from the local hospital was used. As well as this a hierarchy of diagnoses
was used to ensure that the most severe or specific final diagnosis was
acknowledged, with ST-elevation myocardial infarction (STEMI) at the
top of the hierarchy (see Supplementary material online).
Data were extracted from TRAKCare for all admissions (1 October
2013–30 September 2014) with an ICD-10 diagnosis of angina (I200–
I209), myocardial infarction (I210–I229), other IHD (I240–I249), or heart
failure (I50) to ensure complete capture of suspected ACS events. This
was linked to referrals for invasive cardiovascular procedures made
through the SCI-Gateway system, cardiac interventions performed in the
IC of the GJNH and all-cause mortality data from NRS. This linked data
set was then analysed to look at diagnoses and patient characteristics, and
to identify episodes of care, which were then categorized into distinct
clinical care pathways. Those with a final diagnosis of ACS were isolated
for analysis on referrals for invasive cardiovascular procedures, treatment
durations, service delivery metrics and outcomes, including mortality.
After the classification of patients and pathways, data on deprivation
status of patients was provided by the NHS Safe Haven identified based
on the postcode of the patient’s home address and measured using quin-
tiles of the Scottish Index of Multiple Deprivation (SIMD) 2012 meas-
ure.16,17 Quintile 1 represents the highest level of deprivation with Q5
representing the least deprived. The top 20% most deprived data zones
in Scotland are in the first quintile, with the distribution of Glasgow City’s
data zones being 49%, 19%, 13%, 10.5%, 8.5% (Q1–Q5).16
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Pre-specified health care outcomes
The pre-specified primary outcomes were 30 day and 1 year all-cause
mortality. The receipt of cardiac interventions, duration of hospital stay
and pathways of care were the pre-specified secondary outcomes.
Data validation
A quality assurance procedure was conducted by the NHS in Glasgow to
assess the robustness of the data extraction process and the accuracy of
the outputs from the analysis programme, as compared with source clin-
ical data assessed and verified by independent, trained observers. The re-
view focused on (i) a quality assessment of 200 individual patient
episodes, taken from a randomly selected calendar month (30 days) of
the e-Registry with all consecutive episodes included, and (ii) an assess-
ment of the causes of death of 44 patients.
The observers accessed usual care health records using TRAKCare
and other executable systems including Clinical Portal18 and SCI-
STORE19 that are used at the point of care in hospital.
A team of five research nurses with a cardiovascular background em-
ployed by the NHS in Glasgow were tasked with assessing source clinical
data against the data from the e-registry to confirm or query the patient
episodes, including dates and the primary and secondary causes of these
events. In addition, two cardiologists (K.M., C.B.) assessed any queries
that were raised by the research nurses.
The reviewers focused on 4 aspects of the analysis programme; care
pathway assignment, diagnosis assignment, assessment of invasive proced-
ures received and assessment of mortality.
Statistical analyses
As this project involved exploratory health services delivery research, a
power calculation was not performed. Categorical variables are ex-
pressed as number and percentage of patients. Most continuous variables
followed a normal distribution and are therefore presented as means to-
gether with standard deviation. Those variables that did not follow a nor-
mal distribution are presented as medians with interquartile range.
Differences in continuous variables between groups were assessed by
the t-test or Mann-Whitney test as appropriate. Differences in categorical
variables between groups were assessed using the Fisher’s test. Cox pro-
portional hazards regressions were used to evaluate the effect of risk fac-
tors and intervention procedures on all-cause mortality for ST-segment
elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) pa-
tients. Multivariable logistic or zero-inflated negative binomial models
were performed to evaluate differences in service delivery. Survival analy-
ses will be performed using the Kaplan-Meier method. Analyses were
conducted using SAS Enterprise Guide (v5.1).
Results
Demographics and clinical
characteristics
Between 1 October 2013 and 30 September 2014 (12 months),
2327 unique patients had 2472 distinct episodes of care across 7
acute hospitals and one regional cardiothoracic centre. Of these pa-
tients, the final diagnosis was STEMI in 586 (25.2%) episodes,
NSTEMI in 1068 (45.9%), unspecified MI in 146 (6.3%), and unstable
angina (UA) in 527 (22.6%) for their first hospitalization within the
study period. ST-elevation myocardial infarction patients were gener-
ally younger with a higher proportion of males than the other diag-
noses and relatively more deprived than NSTEMI (77.6% in SIMD
Q1–3 vs. 73.6%) (see Table 1).
Six distinct treatment pathways were identified (Figure 2). The
treatment pathway was mapped for each episode of care giving 53%
Figure 1 Data sources and linkage.
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of patients admitted to the IC; 14% directly as emergency episodes;
3% directly on an elective basis; 7% via local A&E; 21% after an inpa-
tient stay in a local hospital for acute invasive care; and 9% discharged
home from the local hospital for elective invasive care at a later date.
The other 47% stayed within the local hospital only, either managed
conservatively with no following invasive treatment or dying in hos-
pital (Table 1).
As expected and dictated by local protocol, STEMI patients
tend to be admitted to the IC directly or by transfer from the local
A&E for immediate invasive management while NSTEMI patients
tend to be transferred to the IC after admission to a local hospital
(Table 1).
Most records of clinical characteristics and cardiovascular risk fac-
tors came from the IC or electronic referrals for invasive cardiovascu-
lar procedures. These are provided in Tables 2 and 3 for the STEMI and
NSTEMI patients undergoing invasive management, respectively.
Patients not undergoing invasive management did not have these data
recorded as they did not enter a care pathway with systems that pro-
vided this information. Where information was available, patients with
unstable angina/NSTEMI tended to have more concomitant diseases
including hypertension, hypercholesterolaemia, diabetes, a family his-
tory of CHD and histories of MI, PCI, CABG and symptomatic periph-
eral vascular disease than patients with STEMI. However, patients with
STEMI were more likely to be current smokers.
....................................................................................................................................................................................................................
Table 1 Demographic characteristics by final diagnosis
All
(n52327)
STEMI
(n5 586)
NSTEMI
(n5 1068)
Unspecified MI
(n5 146)
Unstable angina
(n5 527)
Age at admission (years) 67.5 (13.9) 62.8 (14.2) 68.4 (13.4) 77.0 (11.6) 68.3 (13.2)
Gender
Female 989 (42.5%) 182 (31.1%) 458 (42.9%) 70 (47.9%) 279 (52.9%)
Male 1338 (57.5%) 404 (68.9%) 610 (57.1%) 76 (52.1%) 248 (47.1%)
Ethnicity
White 1636 (70.4%) 404 (69.2%) 650 (60.9%) 130 (89.0%) 452 (85.8%)
Other 48 (2.1%) 8 (1.4%) 23 (2.2%) 4 (2.7%) 13 (2.5%)
Unknown 643 (27.6%) 174 (29.5%) 395 (37.0%) 12 (8.2%) 62 (11.8%)
Missing 2 2 0 0 0
SIMD quintile
Q1 (most deprived) 906 (43.6%) 214 (41.2%) 407 (43.4%) 63 (44.7%) 222 (46.3%)
Q2 372 (17.9%) 95 (18.3%) 167 (17.8%) 24 (17.0%) 86 (18.0%)
Q3 293 (14.1%) 94 (18.1%) 116 (12.4%) 25 (17.7%) 58 (12.1%)
Q4 245 (11.8%) 50 (9.6%) 113 (12.0%) 15 (10.6%) 67 (14.0%)
Q5 (least deprived) 262 (12.6%) 67 (12.9%) 135 (14.4%) 14 (9.9%) 46 (9.6%)
Missing 249 66 130 5 48
Pathway
Emergency direct to IC 333 (14.3%) 304 (51.9%) 29 (2.7%) 0 (0.0%) 0 (0.0%)
Local A&E to IC 155 (6.7%) 148 (25.3%) 7 (0.7%) 0 (0.0%) 0 (0.0%)
Acute invasive 492 (21.1%) 57 (9.7%) 426 (39.9%) 2 (1.4%) 7 (1.3%)
Elective invasive 208 (8.9%) 5 (0.9%) 198 (18.5%) 0 (0.0%) 5 (0.9%)
Local hospital only 1081 (46.5%) 68 (11.6%) 364 (34.1%) 144 (98.6%) 505 (95.8%)
Elective direct to IC 58 (2.5%) 4 (0.7%) 44 (4.1%) 0 (0.0%) 10 (1.9%)
Data are mean (SD) or number (%).
SIMD, Scottish Index of Multiple Deprivation; IC, Invasive Centre.
For first admission in study period.
Figure 2 All acute coronary syndrome patients (1st hospitaliza-
tion in timeframe) by care pathway. Note sizes are proportional to
percentage of analysis population. Pathway definitions: 1—
Emergency direct admission to invasive centre [Golden Jubilee
National Hospital (GJNH)]; 2—Local A&E in regional hospital fol-
lowed by direct transfer to invasive centre; 3—Admission to local
hospital followed by inter-hospital transfer to the invasive centre
(acute invasive); 4—Admission to local hospital followed by referral
to the invasive centre on an urgent outpatient basis (elective inva-
sive); 5—Local hospital only (no referral for invasive management);
6—Elective direct to the invasive centre (no local hospital referral).
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Service Delivery
Intervention rates and the mean number of days to invasive pro-
cedure varied depending on care pathway. The mean total dur-
ation of hospital stay for all patients with a diagnosis of STEMI was
lower than for all patients with a diagnosis of NSTEMI (5.5, 95% CI
4.8–6.2 days vs. 7.5, 95% CI 6.8–8.1 days; P< 0.0001). These dur-
ations include both those in invasive and non-invasive pathways.
Among all patients with STEMI (including those who remained in
the local hospital), 470 (80.2%) underwent reperfusion therapy by
percutaneous coronary intervention (PCI), while NSTEMI (33.1%) and
UA (1.9%) patients underwent revascularization by PCI significantly
less frequently. For patients managed invasively, STEMI bed days after
intervention were higher than for NSTEMI (1.4, 95% CI 1.3–1.5 days
vs. 1.1, 95% CI 1.0–1.2 days; P< 0.0001) whereas NSTEMI patients
spent longer in hospital prior to intervention (0.7, 95% CI 0.4–1.0 days
vs. 4.4, 95% CI 4.0–4.8 days; P< 0.0001). This finding is related to the
differences observed in the repatriation of patients to local hospitals
depending on a STEMI or NSTEMI diagnosis. 85.3% of STEMI patients
treated in the IC were repatriated following treatment as compared to
19.9% of NSTEMI patients, who tended to be discharged home directly
from the IC. Other characteristics of service delivery by diagnosis (all
pathways combined) are provided in the Supplementary material on-
line, Table S8.
....................................
.................................................................................................
Table 2 Clinical characteristics for ST-elevation
myocardial infarction patients undergoing invasive
treatment by intervention
Angiogram PCI after angiogram
Yes
(n5 504)
No
(n5 36)
Yes
(n5 468)
Risk factors
Age at admission (years) 60.9 (13.1) 59.0 (16.2) 61.0 (12.8)
Gender
Female 142 (28.2%) 6 (16.7%) 136 (29.1%)
Male 362 (71.8%) 30 (83.3%) 332 (70.9%)
SIMD quintile
Q1 (most deprived) 184 (36.5%) 10 (27.8%) 174 (37.2%)
Q2 83 (16.5%) 3 (8.3%) 80 (17.1%)
Q3 82 (16.3%) 6 (16.7%) 76 (16.2%)
Q4 45 (8.9%) 4 (11.1%) 41 (8.8%)
Q5 (least deprived) 56 (11.1%) 5 (13.9%) 51 (10.9%)
Hypertension 190 (37.7%) 16 (44.4%) 174 (37.2%)
Hypercholesterolaemia 162 (32.1%) 12 (33.3%) 150 (32.1%)
Diabetes 36 (7.1%) 3 (8.3%) 33 (7.1%)
Smoking status
Current 250 (49.6%) 11 (30.6%) 239 (51.1%)
Ex 101 (20.0%) 14 (38.9%) 87 (18.6%)
Never 119 (23.6%) 6 (16.7%) 113 (24.1%)
Family history of CHD 192 (38.1%) 13 (36.1%) 179 (38.2%)
Medical history
Previous PCI 54 (10.7%) 2 (5.6%) 52 (11.1%)
Previous cardiac surgery
CABG 10 (2.0%) 1 (2.8%) 9 (1.9%)
CABG; valve 2 (0.4%) 0 (0.0%) 2 (0.4%)
None/missing 490 (97.2%) 35 (97.2%) 455 (97.2%)
Other cardiac 1 (0.2%) 0 (0.0%) 1 (0.2%)
Valve 1 (0.2%) 0 (0.0%) 1 (0.2%)
Previous MI 73 (14.5%) 6 (16.7%) 67 (14.3%)
Data are mean (SD) or number (%) out of group total.
CABG, coronary artery bypass grafting surgery; CHD, coronary heart disease;
PCI, percutaneous coronary intervention; SIMD, Scottish Index of Multiple
Deprivation.
.....................................
.................................................................................................
Table 3 Clinical characteristics for non-ST-elevation
myocardial infarction patients undergoing invasive
treatment by intervention
Angiogram PCI after angiogram
Yes
(n5 678)
No
(n5 334)
Yes
(n5 344)
Risk factors
Age at admission (years) 63.7 (11.7) 63.8 (11.7) 63.7 (11.7)
Gender
Female 253 (37.3%) 133 (39.8%) 120 (34.9%)
Male 425 (62.7%) 201 (60.2%) 224 (65.1%)
SIMD quintile
Q1 (most deprived) 263 (38.8%) 140 (41.9%) 123 (35.8%)
Q2 104 (15.3%) 47 (14.1%) 57 (16.6%)
Q3 76 (11.2%) 39 (11.7%) 37 (10.8%)
Q4 64 (9.4%) 31 (9.3%) 33 (9.6%)
Q5 (least deprived) 85 (12.5%) 33 (9.9%) 52 (15.1%)
Hypertension 363 (53.5%) 179 (53.6%) 184 (53.5%)
Hypercholesterolaemia 297 (43.8%) 146 (43.7%) 151 (43.9%)
Diabetes 67 (9.9%) 28 (8.4%) 39 (11.3%)
Smoking status
Current 221 (32.6%) 98 (29.3%) 123 (35.8%)
Ex 166 (24.5%) 82 (24.6%) 84 (24.4%)
Never 222 (32.7%) 119 (35.6%) 103 (29.9%)
Family history of CHD 299 (44.1%) 144 (43.1%) 155 (45.1%)
BMI (kg/m2) 29.0 (5.7) 28.8 (5.9) 29.2 (5.6)
Missing 129 59 70
GRACE Score 134.9 (37.6) 135.2 (39.2) 134.6 (36.0)
Missing 89 38 51
Medical history
Previous PCI 101 (14.9%) 47 (14.1%) 54 (15.7%)
Previous Cardiac Surgery
CABG 41 (6.0%) 18 (5.4%) 23 (6.7%)
CABG; Valve 1 (0.1%) 0 (0.0%) 1 (0.3%)
Congenital cardiac 1 (0.1%) 0 (0.0%) 1 (0.3%)
None/missing 628 (92.6%) 313 (93.7%) 315 (91.6%)
Other cardiac 5 (0.7%) 2 (0.6%) 3 (0.9%)
Valve 2 (0.3%) 1 (0.3%) 1 (0.3%)
Previous MI 173 (25.5%) 90 (26.9%) 83 (24.1%)
Data are mean (SD) or number (%) out of group total. GRACE scores are re-
corded at time of referral.
BMI, body mass index; CABG, coronary artery bypass grafting surgery; CHD, cor-
onary heart disease; PCI, percutaneous coronary intervention; SIMD, Scottish
Index of Multiple Deprivation.
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Of the episodes of care where a STEMI patient accessed the IC for
intended invasive treatment, 90.7% of episodes involved the patient
receiving PCI. The median door-to-balloon (time from arrival at IC to
receipt of PCI) (DTB) and call-to-balloon (time from call to emer-
gency services to receipt of PCI) (CTB) times were 22 and 95 min, re-
spectively for STEMI patients (Table 4). This compares favourably to
the median DTB and CTB times presented in the most recent
MINAP Annual Report5 for England which were 41 min and 115 min,
respectively. Myocardial Ischaemia National Audit Project also meas-
ures the proportions of STEMI patients who receive their PCI against
different time metrics. Times to receipt of PCI for patients treated in
Glasgow again compare favourably to England for all reported met-
rics; proportion of patients receiving PCI within (i) 90 min of arriving
at IC (Glasgow 98.5% vs. England 88.9%), (ii) 150 min of call for help
whether direct or transfer (85.9% vs. 82.3%), (iii) 150 min of call for
help with direct admission (94.8% vs. 82.8%), (iv) 150 min of call for
help admitted by transfer (60.9% vs. 50.5%), and (v) 120 min of call
for help with direct admission (87.5% vs. 53.9%).
For the 63.5% of NSTEMI patients who were referred to the IC
for intended invasive treatment, 96.3% underwent angiography, but
only 50.3% then went on to have PCI. In comparison, the MINAP re-
port indicates that 79.0% of patients in England were referred for
angiography during their admission for NSTEMI in 2014–2015. The
proportion of NSTEMI patients seen by a cardiologist for Glasgow
and England were also able to be compared (93.3% vs. 95.1%). Time
to angiography for NSTEMI patients differed by pathway of care
(Table 4). For NSTEMI patients referred to the IC via the acute inva-
sive pathway, median time to angiography was 4 days with 25%
receiving angiography within 2 days and 75% receiving angiography
within 6 days. For those who accessed the IC via the elective invasive
pathway median time to angiography was 23 days (IQR 16–29 days).
Associations with all-cause mortality and
service delivery
The unadjusted all-cause mortality rate at 30 days was 9.0% in all
STEMI patients and 3.0% in all NSTEMI patients rising to 11.9% in
STEMI and 11.6% in NSTEMI at 1 year. Age-, gender-, and pathway-
adjusted 30-day mortality in STEMI was significantly higher than that
in NSTEMI (HR 4.63, 95% CI 2.7–7.92) and remains higher at 1 year
(HR 1.72, 95% CI 1.16–2.53).
Age-adjusted associations of all-cause death in STEMI and NSTEMI
patients at 30 days (Table 5) and 1 year (Figure 3 and 4) were as-
sessed. Compared to conservative non-invasive treatment, the re-
ceipt of angiography alone is not associated with increased survival at
30 days or 1 year in STEMI patients but the receipt of PCI was associ-
ated with higher survival (30 days: HR 3.07, 95% CI 1.61–5.85, 1 year:
HR 3.06, 95% CI 1.75–5.34). Initial presentation in a local hospital
....................................................................................................................................................................................................................
Table 4 Service delivery by pathway for ST-elevation myocardial infarction and non-ST-elevation myocardial
infarction for those intended for invasive treatment
All Emergency
direct to IC
Local A&E
to IC
Acute
invasive
Elective
invasive
Elective direct
to IC
STEMI (n) 518 304 148 57 5 4
Receipt of coronary angiography
Yes 504 (97.3%) 301 (99.0%) 146 (98.6%) 49 (86.0%) 5 (100.0%) 3 (75.0%)
No 14 (2.7%) 3 (1.0%) 2 (1.4%) 8 (14.0%) 0 (0.0%) 1 (25.0%)
Duration from admission to angiography (days) 0 [0, 0] 0 [0, 0] 0 [0, 0] 1 [0, 3] 18 [18, 21] 0 [0, 0]
Receipt of PCI
Yes 470 (90.7%) 285 (93.8%) 138 (93.2%) 40 (70.2%) 3 (60.0%) 4 (100.0%)
No 48 (9.3%) 19 (6.3%) 10 (6.8%) 17 (29.8%) 2 (40.0%) 0 (0.0%)
Duration from admission to PCI (days) 0 [0, 0] 0 [0, 0] 0 [0, 0] 1 [0, 3] 21 [11, 23] 0 [0, 0]
Call-to-balloon (min) 95 [83, 116] 91 [81, 104] 132 [99, 191] 76 [74, 108] NR NR
n 325 232 87 5 NR NR
Door-to-balloon (min) 22 [18, 27] 21 [18, 27] 22 [18, 29] 25 [14, 27] NR NR
n 400 263 126 10 NR NR
NSTEMI (n) 704 29 7 426 198 44
Receipt of coronary angiography
Yes 678 (96.3%) 27 (93.1%) 7 (100.0%) 408 (95.8%) 198 (100.0%) 38 (86.4%)
No 26 (3.7%) 2 (6.9%) 0 (0.0%) 18 (4.2%) 0 (0.0%) 6 (13.6%)
Duration from admission to angiography (days) 5 [2, 14] 0 [0, 0] 0 [0, 0] 4 [2, 6] 23 [16, 29] 0 [0, 0]
Receipt of PCI
Yes 354 (50.3%) 18 (62.1%) 6 (85.7%) 233 (54.7%) 72 (36.4%) 25 (56.8%)
No 350 (49.7%) 11 (37.9%) 1 (14.3%) 193 (45.3%) 126 (63.6%) 19 (43.2%)
Duration from admission to PCI (days) 4 [1, 9] 0 [0, 0] 0 [0, 0] 4 [2, 6] 23 [15, 27] 0 [0, 0]
The recommended call-to-balloon time is within 150 min and door-to-balloon time within 90 min for STEMI.5,20 The recommended duration from admission to angiography for
NSTEMI is within 72 h (3 days).21 Data are number (%) or median [IQR]. Where duration from admission to angiography/PCI is 0 days, this means the procedure happened on
the same day as admission.
NR, Not relevant.
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Table 5 Associations with 30-day mortality in all ST-elevation myocardial infarction and non-ST-elevation myocardial
infarction patients
30-day mortality and associations STEMI NSTEMI
Hazard ratio
(95% CI)
P-value Hazard ratio
(95% CI)
P-value
Age (5 year) 1.31 (1.18, 1.46) <0.0001 1.44 (1.23, 1.69) <0.0001
Male vs. female 1.05 (0.59, 1.87) 0.8717 1.82 (0.88, 3.77) 0.1056
SIMD quintile 0.1148 0.7562
Q2 vs. Q1 0.61 (0.22, 1.64) 1.20 (0.45, 3.20)
Q3 vs. Q1 1.60 (0.77, 3.29) 1.08 (0.35, 3.36)
Q4 vs. Q1 1.04 (0.41, 2.67) 1.46 (0.55, 3.89)
Q5 vs. Q1 0.27 (0.06, 1.19) 0.57 (0.16, 2.03)
Admission to local hospital vs.
direct admission to IC (all patients)
1.86 (1.04, 3.32) 0.0363 NA
Admission to local hospital vs.
direct admission to IC (patients intended
for invasive management)
0.70 (0.21, 2.28) 0.5488 NA
GRACE (low vs. high) NA 0.31 (0.02, 4.86) 0.4019
Invasive management 0.0012 0.0082
None vs. angiogram only 1.10 (0.40, 3.05) 6.95 (1.55, 31.17)
None vs. angiogram and PCI 3.07 (1.61, 5.85) 3.66 (1.18, 11.40)
Angiogram only vs. angiogram and PCI 2.79 (1.08, 7.25) 0.53 (0.10, 2.88)
Local admitting hospital NA 0.2376
Hospital 2 vs. 1 0.21 (0.03, 1.58)
Hospital 3 vs. 1 0.89 (0.37, 2.16)
Hospital 4 vs. 1 1.04 (0.30, 3.66)
Hospital 5 vs. 1 —
Hospital 6 vs. 1 0.39 (0.11, 1.38)
Hospital 7 vs. 1 0.20 (0.05, 0.89)
GRACE scores are recorded at time of referral. GRACE score: low (<_140), high (>140).
IC, Intervention Centre; PC, percutaneous coronary intervention; SIMD, Scottish Index of Multiple Deprivation; Q1, most deprived; Q5, least deprived.
Age (5 years)
Male vs Female
SIMD quintile
    Q2 vs Q1
    Q3 vs Q1
    Q4 vs Q1
    Q5 vs Q1
Invasive management
    None vs Angiogram only
    None vs Angiogram & PCI
    Angiogram only vs Angiogram & PCI
Weekday vs weekend admission
Admission to local hospital vs direct to IC
0.12 0.25 0.50 1.0 2.0 4.0 7.0
Hazard Ratio (95%CI)
Figure 3 Associations with all-cause mortality at 1 year for ST-elevation myocardial infarction patients. SIMD, Scottish Index of Multiple
Deprivation. Q1 represents the highest level of deprivation.
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compared to being admitted to the IC directly is associated with
higher mortality for STEMI patients (30 days: HR 1.86, 95% CI 1.04–
3.32; P= 0.036, 1 year: HR 1.96, 95% CI 1.19–3.24; P= 0.009) but the
association disappears after adjusting for the rate of PCI performed.
For NSTEMI patients, the receipt of angiography alone (30 days: HR
6.95, 95% CI 1.55–31.17, 1 year: HR 4.03, 95% CI 2.17–7.48) and
angiography with follow-on PCI (30 days: HR 3.66, 95% CI 1.18–
11.40, 1 year: HR 4.68, 95% CI 2.48–8.83) are both associated with
higher survival, with no statistically significant difference between the
two. GRACE score was predictive of all-cause mortality at 1-year
for NSTEMI (P= 0.021) but not at 30 days (P= 0.402). There was no
difference in 30-day (P= 0.238) or 1 year (P= 0.676) mortality be-
tween local admitting hospitals.
All-cause mortality by diagnosis and management is shown in
Figure 5. Age-adjusted associations of service delivery are shown in
Table 6. If referred for intervention, NSTEMI patients with high
GRACE scores tend to be fast-tracked through an acute invasive
pathway (P< 0.001) but did not differ in the rate of angiography or
PCI compared to those referred with low GRACE scores. Males
experiencing NSTEMI were more likely to undergo angiography (OR
Age (5 years)
Male vs Female
SIMD quintile
    Q2 vs Q1
    Q3 vs Q1
    Q4 vs Q1
    Q5 vs Q1
Invasive management
    None vs Angiogram only
    None vs Angiogram & PCI
    Angiogram only vs Angiogram & PCI
Weekday vs weekend admission
GRACE Low vs High
Local admitting hospital
    Hospital 2 vs 1
    Hospital 3 vs 1
    Hospital 4 vs 1
    Hospital 5 vs 1
    Hospital 6 vs 1
    Hospital 7 vs 1
0.03 0.06 0.13 0.25 0.50 1.00 2.00 4.00 8.00
Hazard Ratio (95%CI)
Figure 4 Associations with all-cause mortality at 1 year for non-ST-segment elevation myocardial infarction patients. SIMD, Scottish Index of
Multiple Deprivation. Q1 represents the highest level of deprivation.
Figure 5 The Kaplan–Meier plot for all-cause mortality by diagnosis and management.
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Table 6 Associations with service delivery in all ST-elevation myocardial infarction and non-ST-elevation myocardial
infarction patients
Service delivery and associations STEMI NSTEMI
Odds ratio/estimate
(95% CI)
P-value Odds ratio/estimate
(95% CI)
P-value
Angiography (%) 86.0 63.5
Age (5 year) 0.68 (0.61, 0.75) <0.0001 0.64 (0.60, 0.69) <0.0001
Male vs. Female 1.43 (0.85, 2.41) 0.1742 1.40 (1.06, 1.87) 0.0198
SIMD quintile 0.4777 0.6751
Q2 vs. Q1 1.23 (0.56, 2.68) 0.90 (0.59, 1.38)
Q3 vs. Q1 1.48 (0.68, 3.24) 1.09 (0.67, 1.79)
Q4 vs. Q1 2.62 (0.90, 7.60) 0.92 (0.57, 1.49)
Q5 vs. Q1 1.19 (0.63, 2.68) 1.31 (0.83, 2.09)
Admission to local hospital vs. direct admission to IC 0.01 (0.01, 0.03) <0.0001 NA
GRACE (low vs. high) NA 2.36 (0.71, 7.83) 0.1590
Local admitting hospital NA 0.0111
Hospital 2 vs. 1 0.52 (0.30, 0.90)
Hospital 3 vs. 1 1.00 (0.65, 1.55)
Hospital 4 vs. 1 0.80 (0.41, 1.55)
Hospital 5 vs. 1 —
Hospital 6 vs. 1 0.45 (0.29, 0.71)
Hospital 7 vs. 1 0.75 (0.48, 1.16)
Percutaneous coronary intervention (%) 80.2 33.1
Age (5 year) 0.79 (0.73, 0.86) <0.0001 0.82 (0.78, 0.86) <0.0001
Male vs. female 1.13 (0.72, 1.78) 0.5949 1.41 (1.08, 1.85) 0.0132
SIMD quintile 0.8286 0.1363
Q2 vs. Q1 1.30 (0.66, 2.53) 1.29 (0.87, 1.92)
Q3 vs. Q1 1.12 (0.59, 2.12) 1.17 (0.74, 1.84)
Q4 vs. Q1 1.44 (0.63, 3.30) 1.19 (0.74, 1.90)
Q5 vs. Q1 0.91 (0.46, 1.81) 1.75 (1.15, 2.68)
Admission to local hospital vs. direct admission to IC 0.04 (0.02, 0.07) <0.0001 NA
GRACE (low vs. high) NA 0.83 (0.55, 1.24) 0.3566
Local admitting hospital NA 0.1059
Hospital 2 vs. 1 0.80 (0.46, 1.38)
Hospital 3 vs. 1 1.13 (0.76, 1.70)
Hospital 4 vs. 1 0.93 (0.50, 1.74)
Hospital 5 vs. 1 —
Hospital 6 vs. 1 0.61 (0.38, 0.97)
Hospital 7 vs. 1 1.29 (0.86, 1.92)
Referral to intervention centre (invasive transfer
vs. local hospital only) (%)
47.7 63.2
Age (5 year) 0.66 (0.56, 0.77) <0.0001 0.64 (0.59, 0.68) <0.0001
Male vs. female 1.84 (0.76, 4.48) 0.1774 1.31 (0.97, 1.77) 0.0751
SIMD quintile 0.0843 0.6356
Q2 vs. Q1 1.57 (0.42, 5.91) 0.96 (0.62, 1.50)
Q3 vs. Q1 1.17 (0.30, 4.59) 1.15 (0.69, 1.91)
Q4 vs. Q1 5.14 (1.23, 21.42) 0.98 (0.60, 1.61)
Q5 vs. Q1 0.39 (0.09, 1.66) 1.41 (0.87, 2.29)
Local admitting hospital NA 0.0301
Hospital 2 vs. 1 0.61 (0.35, 1.07)
Hospital 3 vs. 1 0.98 (0.63, 1.52)
Hospital 4 vs. 1 0.81 (0.41, 1.58)
Hospital 5 vs. 1 —
Hospital 6 vs. 1 0.46 (0.29, 0.73)
Continued
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1.40, 95% CI 1.06–1.87) and PCI (OR 1.41, 95% CI 1.08–1.85) than fe-
males but gender was not apparently associated with whether a pa-
tient was referred to the intervention centre (OR 1.31, 95% CI 0.97–
1.77) or whether a referral was acute invasive or elective invasive
(OR 1.14, 95% CI 0.80–1.64). However, crude referral rates for fe-
males and males were 55.1% and 69.0%, respectively, suggesting that
there is a numerical difference between gender. In those referred, fe-
male patients tended to have higher GRACE scores with 48.2% hav-
ing a GRACE score >140 vs. 40.9% in males. Male gender was not
associated with increased 30-day or 1-year mortality. Males were
more likely than females to be diagnosed with NSTEMI vs. unstable
angina (OR 1.50, 95% CI 1.22–1.85). Younger patients were more
likely to be referred for angiography and PCI, but if referred, older pa-
tients tended to be fast-tracked through an acute invasive pathway,
likely to be in part explained by the effect of age on the GRACE
score. There was a large proportion (46%) of NSTEMI patients
referred for angiography that did not receive follow-on PCI. Referral
and angiography rates for NSTEMI patients differed significantly de-
pending on the local admitting hospital (P= 0.03 and P= 0.011, re-
spectively). Local admitting hospital also had an association with
whether a patient was referred to the IC via an acute or elective inva-
sive pathway (P< 0.0001) as well as the time from local hospital refer-
ral to receipt of PCI (P< 0.0001). Despite the differences in
angiography referrals, there was ultimately no significant association
between local admitting hospital and receipt of PCI (Table 6).
A patient’s deprivation status (as measured by the SIMD) was not
seen to be associated with either mortality at 30 days or 1 year, or
the pathway of care for STEMI or NSTEMI patients including delivery
of angiography or PCI.
Outcome of data validation
Following review of source clinical data, pathway assignment was
confirmed to be correct in all [n= 200 (100%)] of the patient epi-
sodes. The diagnosis assignment was confirmed in 199 (99%) and one
........................................................ ........................................................
....................................................................................................................................................................................................................
Table 6 Continued
Service delivery and associations STEMI NSTEMI
Odds ratio/estimate
(95% CI)
P-value Odds ratio/estimate
(95% CI)
P-value
Hospital 7 vs. 1 0.71 (0.46, 1.11)
Acute vs. elective invasive transfer (%) 91.9 68.3
Age (5 year) 1.27 (0.88, 1.82) 0.1973 1.25 (1.16, 1.35) <0.0001
Male vs. female — 0.9566 1.14 (0.80, 1.64) 0.4740
SIMD quintile 0.5882 0.1113
Q2 vs. Q1 — 0.54 (0.32, 0.90)
Q3 vs. Q1 0.36 (0.02, 7.72) 0.97 (0.54, 1.76)
Q4 vs. Q1 0.20 (0.01, 5.81) 1.17 (0.60, 2.30)
Q5 vs. Q1 0.10 (0.01, 1.51) 0.72 (0.41, 1.26)
GRACE (low vs. high) NA 0.07 (0.04, 0.13) <0.0001
Local admitting hospital NA <0.0001
Hospital 2 vs. 1 4.50 (1.52, 13.32)
Hospital 3 vs. 1 0.60 (0.36, 0.98)
Hospital 4 vs. 1 0.70 (0.33, 1.48)
Hospital 5 vs. 1 —
Hospital 6 vs. 1 0.33 (0.19, 0.58)
Hospital 7 vs. 1 1.00 (0.58, 1.70)
Time from admission to PCI (days)
Age (5 year) -0.23 (-0.52, 0.05) 0.1050 -0.12 (-0.18, -0.06) <0.0001
Weekday vs. weekend admission 1.08 (-0.36, 2.52) 0.1426 0.03 (-0.29, 0.34) 0.8610
Admission to local hospital vs. direct admission to IC 4.78 (4.01, 5.55) <0.0001 NA
Local admitting hospital NA <0.0001
Hospital 2 vs. 1 -0.43 (-0.91, 0.04)
Hospital 3 vs. 1 0.63 (0.29, 0.97)
Hospital 4 vs. 1 0.15 (-0.36, 0.67)
Hospital 5 vs. 1 —
Hospital 6 vs. 1 0.42 (0.02, 0.82)
Hospital 7 vs. 1 -0.09 (-0.41, 0.23)
GRACE scores are recorded at time of referral. GRACE score: low (<_140) high (>140).
IC, Intervention Centre; PCI, percutaneous coronary intervention; SIMD, Scottish Index of Multiple Deprivation; Q1, Most deprived; Q5, Least deprived.
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subject had missing data. The occurrence of invasive coronary angiog-
raphy, PCI and the dates of these procedures, were confirmed for all
subjects [n= 200 (100%)].
Forty-four individual patient records were included in the verifica-
tion of mortality assignment. All deaths were confirmed. The cause of
death was confirmed to be correct in 100% of the deceased patients
with available records [n= 36 (82%)]. Verification of cause of death
was not possible in eight subjects (18%) in whom primary care re-
cords could not be accessed. The date of death was confirmed cor-
rect in all (100%) subjects.
Discussion
The primary objective of this proof-of-concept project was to imple-
ment a contemporary secondary care e-Registry for patients
hospitalized with suspected or established ACS, utilizing only elec-
tronic records collected as part of usual clinical care in a complex re-
gional health care system; and to be able to produce clinically
meaningful analyses from these data without the need for additional
manual data collection. The pilot has demonstrated that implementa-
tion of an e-registry is possible with the main outcomes being (i) lon-
gitudinal follow-up of patient episodes for all-cause and cause-specific
mortality, (ii) a new system that has potential applications for quality
and health care improvement, service evaluation and electronic
health record-enabled research, and (iii) a system that could enable
reporting for national audit.
The analyses performed on the data suggest possible variation in
standards of care and service delivery for patients experiencing
STEMI and NSTEMI, including differing service provision depending
on the local admitting hospital. As has previously been demonstrated
in other studies, whether a patient receives invasive management or
not is clearly associated with patient outcomes including mortality.
The 2015 ESC Guidelines for the management of ACS in patients
presenting without persistent ST-segment elevation21 recommend
that patients with at least 1 intermediate risk factor should receive
angiography within 72 h (3 days) of hospital admission. At the time of
data extraction for this analysis the acute invasive pathway was the
most likely route through which intermediate to high-risk NSTEMI
patients would access the IC. However, in this pathway less than 50%
of NSTEMI patients achieved this recommendation. Based partly on
the evidence provided by the e-registry a ‘Direct NSTEMI’ service
has recently been implemented whereby patients with high-risk char-
acteristics would be directly transferred by the Ambulance Service to
the IC, rather than the usual admission pathway to the nearest local
hospital. This new service was implemented subsequent to this ana-
lysis, hence the impact of this service change is not captured. There is
the opportunity for evaluation of the impact of the new service
through our e-Registry with subsequent data extracts. These data
provide the opportunity to look at the characteristics of patients and
factors affecting their referral for invasive management to support
identification of patients who will benefit most from an invasive strat-
egy, and potentially to identify the group of patients for whom refer-
ral for angiography is unnecessary, for example those who receive
angiography but do not ultimately require PCI. It is currently un-
known of this group how many go on to receive cardiac surgery in
place of PCI and this will be addressed in the future development of
the data set. In addition to this, the ability to record GRACE score
for patients who remain in the local hospitals would give further in-
sights into the factors associated with the decision to refer for inva-
sive treatment, or not. The differences observed in the rates of
invasive management for male and female patients experiencing
NSTEMI warrants further investigation. The statistical analysis sug-
gests that there is no difference in referral rates between men and
women, however the crude referral rates suggest, at least a numerical
difference. When this is considered in light of a higher proportion of
females referred with a GRACE score greater than 140, it would ap-
pear that males are more likely to be referred for, and to receive,
angiography despite having a larger proportion of low risk scores.
This raises questions about the underlying factors influencing the de-
cision to refer for and perform angiography and PCI. The data from
the e-Registry presents an opportunity to study other factors associ-
ated with gender to better understand the differences in intervention
rates and this is an aspect that will be focused on as part of the con-
tinuation of the project.
Visibility of this type of information is crucial for local clinicians and
decision makers in the NHS to be able to identify focus areas for im-
proved services and outcomes, reduce variation in care and to be
able to measure the impact of any changes made. Since the e-Registry
is based on linkage using the CHI number, other databases could be
linked, such as for drug prescriptions, longer term follow-up in pri-
mary care and the ambulance service. The e-Registry has the poten-
tial to permit queries at the point-of-care in near-real time following
further development of the functionality and creation of an NHS-
Focused reporting system.
The ACS e-Registry has its roots in the UK MINAP with some dif-
ferences. The e-Registry includes variables with definitions that are
identical to those that are collected in MINAP. However, the data in
the e-Registry can be routinely updated based on executable com-
puter programmes, and no additional manual data recording is
needed. Because MINAP involves some de novo manual data report-
ing by individual hospitals, data completeness and accuracy may be
qualified, and this is especially the case for patients with NSTEMI or
unstable angina. The e-Registry makes use of usual care records with-
out de novo data entry, and so, theoretically, patient identification is
more complete as recording of diagnosis in the clinical systems is
mandatory. Comparison with annual figures for myocardial infarction
hospital activity published by Information Services Division (ISD)
Scotland22 shows that the number of cases of MI identified in the
e-Registry is broadly in line with published figures. The methodolo-
gies used for each analysis differ. Certain epidemiological methods
have been applied to the data from the e-Registry to allow meaningful
statistical analysis, such as only considering a patient’s first admission
to hospital in the time period studied, therefore it is difficult to draw
conclusions on the level of similarity. However, taking these factors
into account the number of MI events observed during the study
period is consistent with the expected rate for the population served.
The benefit of near complete case identification from use of elec-
tronic records is contrasted with potential data quality issues. Where
data fields in the clinical systems are not mandatory some clinical de-
tail may be less well reported due to poor completion of non-
mandatory fields, or poor quality and consistency of data recording in
electronic systems.
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Three percent of subjects with an ACS had an elective referral.
This finding was unexpected and may be explained by how episodes
are created. For example, patients with stable symptoms referred on
an elective basis experience an ACS while on the waiting list for inva-
sive management, or the referral for an ACS patient is incorrectly
categorized as elective by the referring clinician (commonly a trainee
doctor). In addition to this, the study period for this analysis started
in October 2013. Prior to this date, we do not have any historical
data for patients, therefore we may be missing information on prior
interactions with the health system which might have been able to
clarify what had happened to these patients. This is likely to become
less of an issue as new data is added to the e-Registry as patients will
have increased history and follow-up.
Despite this limitation, the results of the Data Validation support
the conclusion that data extracted from clinical systems to create this
e-Registry and the analyses that have been performed on the data set
accurately represent what is happening to these patients in the clin-
ical setting. The cause of death for some subjects could not be con-
firmed using secondary care electronic records, especially for
patients who died in the community. This gap points to the need for
enhanced communication between primary and secondary care
health care systems.
The secondary objective to demonstrate the ability of the pharma-
ceutical industry to work as a trusted partner to the NHS and aca-
demia has been successful. Under the Joint Working Agreement, due
to run until April 2019, the skills and resources of all parties have
been deployed equally to deliver the ambition of the e-Registry, with
the NHS providing clinical leadership, Safe Haven and IT system sup-
port, the University providing data science and statistical support and
the industry partner providing project management and analytical
support. The industry partner has had a unique, enabling role in the
development of this e-Registry. Through use of legal and data sharing
agreements between all parties, utilizing project-specific anonymized
data extracts, which protected individual patient identities and limited
access to only appropriate data, the industry partner was able to pro-
vide guidance and expertise to the process of managing and analysing
the data. The involvement of an industry partner also provided a
wider view of the utility and interpretation of the data and brought
knowledge of other available data sources for comparison with the
e-Registry. For the remainder of the agreement the continued collab-
oration between the existing partners and inclusion of other stake-
holders is viewed as vital to the further development of this work.
However, the participation of the industry partner was always
intended to be finite; Onward funding and management of the
e-Registry will then exclusively rest with the NHS in Scotland.
The future development of the e-Registry should involve other re-
gions in NHS Scotland with the aim of developing a national
e-Registry. The current project represents a proof-of-concept ACS
e-Registry in one Health Board (GGC), representing approximately
25% of the population in Scotland and could be rapidly upscaled to
capture additional areas as the electronic systems and pathways for
the other Health Boards in the region are comparable. In addition,
linkage with other health-related databases would enable an end-to-
end picture of management of patients experiencing ACS. Further to
that, by including a broader range of ICD-10 codes for cardiovascular
conditions and procedures, the e-Registry could be expanded to in-
clude a wider range of cardiovascular patient episodes.
Limitations
Utilizing data recorded as part of usual care records without any add-
itional data capture means that some data completeness and quality
issues may exist for non-mandatory or free-text fields. As a result,
many of the clinical characteristics collected within the project were
only available for patients with a particular diagnosis who followed a
particular pathway. The amount of missing data ranged from 0.5% for
history of hypertension in STEMI patients intended for invasive man-
agement, to over 42% of GRACE scores for all NSTEMI patients
(13% in NSTEMI patients referred for angiography). This has shown a
need for improved recording of key data elements and this has been
fed back to the clinical care teams. In addition, using an automated
analysis programme to define episodes of care and categorize the
data can present issues when episodes of care are complex or infor-
mation is incomplete. The assumption that this methodology allows
complete capture of patients experiencing ACS relies on accurate re-
cording of diagnoses in the clinical systems. The e-Registry may not
have complete clinical records for patients due to the limited data
sources included, for example the current lack of data from the pri-
mary care and outpatient settings. This issue is being addressed as
part of further development. This study does not permit inference on
causality, and other interpretations of the data are possible therefore
further development and studies are warranted.
Conclusions
The project has demonstrated that implementation of an e-registry
of ACS hospitalizations from existing health records in a complex
health care system is possible, without the need for additional data
collection or excessive use of NHS resources. It is recommended to
look at the electronic systems used to collect these records and ad-
dress some of the issues surrounding missing data for example mak-
ing certain fields such as GRACE score mandatory. Also additional
guidance for clinicians and administrators should be considered in
order to support the consistency and completeness of routinely col-
lected data as part of quality improvement activities to enable the use
of these data by the NHS to inform clinical practice and patient care.
The data presents further opportunities to study the ACS population
in more detail to gain insights into factors affecting clinical pathways
and outcomes. The Joint Working Project is an example of how the
NHS and pharmaceutical industry can work together to facilitate the
delivery of projects that are valuable to the NHS and patients.
Supplementary material
Supplementary material is available at European Heart Journal – Quality
of Care and Clinical Outcomes online.
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